Cargando…
Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts
OBJECTIVE: To assess the efficacy of monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor in chronic cluster headache (CCH) treatment under real world conditions. BACKGROUND: Calcitonin gene-related peptide has an important pathophysiological role in cluster headach...
Autores principales: | Ruscheweyh, Ruth, Broessner, Gregor, Goßrau, Gudrun, Heinze-Kuhn, Katja, Jürgens, Tim P, Kaltseis, Katharina, Kamm, Katharina, Peikert, Andreas, Raffaelli, Bianca, Rimmele, Florian, Evers, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691634/ https://www.ncbi.nlm.nih.gov/pubmed/32806953 http://dx.doi.org/10.1177/0333102420949866 |
Ejemplares similares
-
Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review
por: Kaltseis, Katharina, et al.
Publicado: (2022) -
The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022) -
Cluster Headache Impact Questionnaire (CHIQ) – a short measure of cluster headache related disability
por: Kamm, Katharina, et al.
Publicado: (2022) -
Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022) -
Primary headache disorders in adolescents in North- and South-Tyrol:
Findings of the EVA-Tyrol-Study
por: Kaltseis, Katharina, et al.
Publicado: (2022)